Is Cryoport France FDA approved?

Cryoport France holds 1 FDA-registered establishment in France. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.

Where are Cryoport France's drugs manufactured?

The FDA register lists PONT DU CHATEAU. Registered operations: active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, repackaging.

Cryoport France

Data as of 24 Sept 2026 · How to read this entry

Request a quote Claim this profile

Registered sites: 1
Active NDC listings: 0
Live patents: 0
Countries: 1
Base: France

Authorisation

Registered operations

Active ingredient (API) manufacture1Labelling1Finished drug manufacture1Packaging1Repackaging1

Sites

Registered establishments

Establishment	Address	Registered for	FEI / DUNS
Cryoport France	ZAC DE CHAMP LAMET RUE DE CHAMBUSSIERE, PONT DU CHATEAU, PUY DE DOME 63430, France (FRA)	Active ingredient (API) manufacture, Labelling, Finished drug manufacture, Packaging, Repackaging	3035999424273157500

Compare

Comparable companies in France

Parfums Christian Dior1 site · 224 NDC
Sevene SAS1 site · 154 NDC
BCM Cosmetique1 site · 72 NDC
Recordati Rare Diseases1 site · 21 NDC
Guerlain1 site · 18 NDC
OPELLA HEALTHCARE INTERNATIONAL SAS1 site · 17 NDC
Valdepharm1 site · 17 NDC
Septodont SAS1 site · 15 NDC
Laboratoires Clarins1 site · 14 NDC
Meribel Pharma Pessac1 site · 8 NDC

Enquiry

Common questions

Is Cryoport France FDA approved?: Cryoport France holds 1 FDA-registered establishment in France. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Cryoport France's drugs manufactured?: The FDA register lists PONT DU CHATEAU. Registered operations: active ingredient (API) manufacture, labelling, finished drug manufacture, packaging, repackaging.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.